Credit Intelligence Limited (ASX. CI1) is one of the leading diversified debt-restructuring and personal insolvency management services operating in Hong Kong in the credit funding sector. Credit Intelligence’s main business includes the provision of bankruptcy admission services and Individual Voluntary Arrangement (IVA) proposal consultancy and implementation services. CI1 is actively looking to grow its business rapidly through acquisitions in Australia and Hong Kong, which will provide synergy to the CI1 group in the Asia Pacific region.

Rhinomed Limited (ASX.RNO) is a Melbourne based ASX listed airway technology company that has developed a simple and innovative nasal stent to improve air flow to the lungs and deliver therapeutic agents. Rhinomed has established a leading position in sports performance enhancement. as testified by athletes including two-time Tour de France winner Chris Froome. The company has three promising product variants and is also developing applications for the delivery of medical cannabis products for conditions including anxiety, pain. allergies, nausea, anxiety and coughs and colds.

Novonix Limited (ASX.NVX) is an integrated developer and supplier of high-performance materials, equipment and services for the global lithium-ion battery industry with operations in the USA and Canada and sales in more than 14 countries. Novonix’s mission is to support the global deployment of lithium-ion battery technologies for a cleaner energy future.